Antibiotic resistance (AR) poses a significant and escalating global health threat, jeopardizing the effective treatment of bacterial infections.  Driven by the overuse and misuse of antibiotics in human and animal healthcare, as well as agriculture, AR leads to increased morbidity, mortality, and healthcare costs.  The emergence and spread of resistant pathogens, including multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteria, are facilitated by horizontal gene transfer and selective pressures.  This necessitates a global, multi-faceted approach to combat AR.  Practical applications include optimizing antibiotic stewardship programs to minimize inappropriate prescribing, promoting infection prevention and control measures in healthcare settings, and developing rapid diagnostic tools for accurate identification of resistant strains.  Investment in research and development of novel antibiotics, alternative therapeutic strategies like phage therapy and antimicrobial peptides, and improved surveillance systems are crucial.  Furthermore, addressing the misuse of antibiotics in agriculture and promoting responsible antibiotic use in low- and middle-income countries are vital for mitigating the global implications of AR and safeguarding public health.  Ultimately, a One Health approach, integrating human, animal, and environmental health, is paramount for effectively tackling this pervasive challenge.